Press Release

Hunter Syndrome Treatment Market 2021 Size & Share | Market worth USD 1118.4 million with 6.0% CAGR by 2027

The global “Hunter Syndrome Treatment Market” is predicted to reach USD 1,118.4 million by 2026, exhibiting a CAGR of 6.0% during the forecast period. The increasing R&D investments by key players for the development of novel therapies to treat rare diseases in patients will be critical factor in boosting the Hunter syndrome treatment market growth during the forecast period. Moreover, the rising clinical studies for diabetes and coronary artery disease (CAD) will have a positive impact on market during the forecast period.

In addition, the surge in rare and genetic diseases will uplift the Hunter syndrome treatment market share. According to the Genetic and Rare Diseases Information Center (GARD), there can be an estimated 7,000 rare diseases and the total number of individuals in the U.S. from these rare diseases can be 25-30 million.

According to the report, published by Fortune Business Insights, tiled “Hunter Syndrome Treatment Market Size, Share & Industry Analysis, By Treatment (Enzyme Replacement Therapy (ERT), and Others), By Route of Administration (Intravenous, and Intracerebroventricular (ICV)/ Intrathecal), By End User (Hospitals, Specialty Clinics and Others), and Regional Forecast, 2019-2026” the market size stood at USD 702.4 million in 2018. The Hunter syndrome treatment market report focuses on demonstrating a complete assessment of the market. It contains facts, thoughtful insights, historical information, industry-validated market information, and projections with a suitable set of assumptions and methodology. It offers valuable insights into all the notable developments of the market. It is created after extensive research followed by an all-encompassing analysis to benefit companies, stakeholders, financers, and potential investors. Moreover, it also includes product launches, acquisitions, collaborations and partnerships, and industry developments.

Major Hunter Syndrome Treatment Market Key players covered in the report include:

  • Shire (Takeda Pharmaceutical Company Limited)
  • Denali Therapeutics
  • ArmaGen
  • Inventiva
  • Green Cross Corp. (GC Pharma)
  • CANbridge Life Sciences Ltd.

Get Request a Sample Copy of the Hunter Syndrome Treatment Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hunter-syndrome-treatment-market-102536

Our research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.

It offers figurative estimations for upcoming years on the basis of the recent developments and historic data. For gathering information and estimating revenue for all segments, researchers have used top-down and bottom-up approaches. On the basis of data collected from primary and secondary research and trusted data sources the report will help both existing and new aspirants for market to figure out and study the market’s needs, market size, and competition.

Hunter Syndrome Treatment Market Analysis 2021:

Competitive Landscape:

Agreement between Clinigen K.K. and GC Pharma to Enable Growth

Clinigen K.K, a Japanese licensed medical supplier, and GC Pharma, a biopharmaceutical company announced a licensing agreement for the manufacturing and commercialization of Hunterase (Idursulfase-beta) ICV, a human recombinant iduronate-2-sulfatase (IDS) used in enzyme replacement therapy for the treatment of Hunter syndrome. The agreement between the two companies can be a critical factor in fostering the growth of the market owing to the methods to aid severe patients and therefore improve their condition. Furthermore, Hunterase ICV will be directly delivered to cerebral ventricles by intracerebroventricular (ICV) administration, in order to reach the cells of the brain and central nervous system. Furthermore, Yoshikazu Nakamura, Representative Director at Clinigen K.K, said “Hunter Syndrome is a complex disease with unmet medical need. We earnestly hope that this product provides significant benefit to patients in Japan.” In addition, President at GC Pharma, Eun Chul, said in statement, “we are delighted to further enhance the value of Hunterase through this partnership, our efforts to make substantial differences in the lives of those with Hunter syndrome in all markets will continue by providing new treatment environments and opportunities.”

Competitive Landscape:

The market in North America generated a revenue of USD 358.9 million in 2018 and is predicted to grow rapidly during the forecast period. The growth in the region is attributed to the high diagnosis and treatment for rare diseases. The growing reimbursement policies for therapies will have a positive impact on the market in the region. Asia Pacific is predicted to witness high growth rate in the forthcoming years owing to the developing healthcare infrastructure. Also, the presence of major players in the region will bolster healthy growth in Asia Pacific. In addition, ongoing clinical trials will boost the Hunter syndrome treatment market trends in the forthcoming years. For instance, the Phase 1/2 clinical trial conducted and initiated by Prof. Torayuki Okuyama in National Center for Child Health and Development in Japan showed a significant decrease in Heparan sulfate which causes mental retardation.

Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/hunter-syndrome-treatment-market-102536

Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Pipeline Analysis
    • Key Industry Developments
    • Regulatory Scenario by Key Regions
    • Overview of Emerging Treatments for Hunter Syndrome
    • Reimbursement Scenario by Key Regions
  • Global Hunter Syndrome Treatment Market Analysis, Insights and Forecast, 2014-2025
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Treatment
      • Enzyme Replacement Therapy (ERT)
      • Others
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Intravenous
      • Intracerebroventricular (ICV)/ Intrathecal
    • Market Analysis, Insights and Forecast – By End User
      • Hospitals
      • Specialty Clinics
      • Others
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Rest of the World
  • North America Hunter Syndrome Treatment Market Analysis, Insights and Forecast, 2014-2025
    • Key Findings / Summary
    • Market Analysis – By Treatment
      • Enzyme Replacement Therapy (ERT)
      • Others
    • Market Analysis – By Route of Administration
      • Intravenous
      • Intracerebroventricular (ICV)/ Intrathecal
    • Market Analysis – By End User
      • Hospitals
      • Specialty Clinics
      • Others
    • Market Analysis – By Country
      • U.S.
      • Canada
  • Europe Hunter Syndrome Treatment Market Analysis, Insights and Forecast, 2014-2025
    • Key Findings / Summary
    • Market Analysis – By Treatment
      • Enzyme Replacement Therapy (ERT)
      • Others
    • Market Analysis – By Route of Administration
      • Intravenous
      • Intracerebroventricular (ICV)/ Intrathecal
    • Market Analysis – By End User
      • Hospitals
      • Specialty Clinics
      • Others
    • Market Analysis – By Country/ sub-region
      • U.K.
      • Germany
      • France
      • Spain
      • Italy
      • Rest of Europe
  • Asia pacific Hunter Syndrome Treatment Market Analysis, Insights and Forecast, 2014-2025
    • Key Findings / Summary
    • Market Analysis – By Treatment
      • Enzyme Replacement Therapy (ERT)
      • Others
    • Market Analysis – By Route of Administration
      • Intravenous
      • Intracerebroventricular (ICV)/ Intrathecal
    • Market Analysis – By End User
      • Hospitals
      • Specialty Clinics
      • Others
    • Market Analysis – By Country/ sub-region
      • Japan
      • China
      • India
      • South Korea
      • Rest of Asia Pacific

Toc Continue…

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune -411045, Maharashtra, India.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

 

Related Reports :

Indirect Calorimeter Market

Indirect Calorimeter Market Size

Indirect Calorimeter Market Share

Indirect Calorimeter Market Trends

Indirect Calorimeter Market Growth

Medical Non-Woven Disposables Market Analysis

Medical Non-Woven Disposables Market Business Opportunities

Medical Non-Woven Disposables Market Key Players

Medical Non-Woven Disposables Market Demand

Medical Non-Woven Disposables Market Competitive Landscape

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close